Press Releases September 3, 2026 08:00 AM

Weight Watchers to Participate in Morgan Stanley Annual Global Healthcare Conference

Weight Watchers to Present at Morgan Stanley Annual Global Healthcare Conference, Highlighting Leadership in Science-Backed Weight Management

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
WW

WW International, Inc. (Weight Watchers), a leader in science-backed weight management, announced its participation in the Morgan Stanley Annual Global Healthcare Conference. The company will discuss its integrated support system combining scientific expertise, medication including GLP-1 drugs, technology, and human connection to deliver personalized weight management solutions. The fireside chat will be webcast live and replayed for investors and the public.

Weight Watchers to Participate in Morgan Stanley Annual Global Healthcare Conference
WW
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Weight Watchers highlights its integrated, science-based approach to weight management, incorporating GLP-1 medications which are gaining prominence in obesity treatment.
  • The company leverages technology, personalized coaching, and clinical interventions to deliver a comprehensive weight management program.
  • Participation in a leading healthcare conference underscores Weight Watchers' strategic engagement with healthcare investors and the growing medicalized weight loss sector.

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that the Company will be participating in the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15th. The fireside chat is scheduled to begin at 2:35 p.m. ET. 

The fireside chat will be accessible via live audio webcast on the Company’s corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days.

About Weight Watchers
Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.

For investor inquiries, please contact:
Anna Kate Heller
[email protected]

For media inquiries, please contact:
Melissa Garbayo
[email protected]


Risks

  • Market competition in weight management and health tech sectors could challenge Weight Watchers' growth and market share.
  • Regulatory environment and access to GLP-1 medications may affect program accessibility and costs.
  • Dependence on consumer adoption of paid programs and sustained member engagement introduces business model risks.

More from Press Releases

Final Opportunity to Own a New Luxury Home in Toll Brothers at Tesoro Highlands - Alta Monte Collection in Valencia, California Sep 3, 2026 Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States Sep 3, 2026 CN Reports August Grain Movement Sep 3, 2026 Wellchange Holdings Company Limited Announces 1-for-5 Reverse Stock Split Effective September 8, 2026 Sep 3, 2026 Cosmos Health: A Company Transformed Sep 3, 2026